Elipovimab

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameElipovimab
Drug Alias NameGS-9722
ClassificationBiologics
Mechanisms of ActionHIV envelope protein gp120 inhibitorsTransmembrane glycoprotein gp41 inhibitors
TargetsHIV envelope protein gp120Transmembrane glycoprotein gp41
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGilead Inc
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences Inc
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A